ArticleCureus2026
Reducing Diagnostic Delays in Head and Neck Cancer Through Surgeon-Performed Ultrasound-Guided Fine-Needle Aspiration and Same-Day Cytology Results.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThere is increasing interest among ear, nose, and throat (ENT) surgeons in performing ultrasound and ultrasound-guided fine-needle aspiration biopsy (US-FNAB). Surgeon-performed ultrasound has the potential to streamline the diagnostic pathway and reduce waiting times for patients evaluated for suspected head and neck cancer. However, concerns have been raised about diagnostic accuracy when surgeons, rather than radiologists, perform US-FNAB. This study aimed to assess the diagnostic quality and time to diagnosis of surgeon-performed US-FNAB with same-day cytology for all patients referred to an academic head and neck cancer outpatient clinic.
methodsThis retrospective study reviewed patients' records from a fast-track head and neck cancer outpatient clinic. All patients underwent surgeon-performed US-FNAB with same-day final cytological evaluation by a dedicated cytopathologist. Data included demographics, biopsy site, cytology and histology results, and time from referral to a diagnostic plan. The primary outcome was the inadequacy rate of US-FNAB from cytology reports, while the secondary outcomes included the time to diagnostic plan and diagnostic accuracy. The time to the diagnostic plan was defined as the time from referral to the establishment of a final diagnostic plan. Diagnostic accuracy was assessed using US-FNAB results and final histology diagnoses when available.
resultsA total of 155 US-FNAB samples from 117 patients were analyzed. The overall inadequacy rate was 11%, with the highest rate observed in thyroid lesions (five of 23; 21.7%). No significant difference was found between residents (5.6%) and consultants (15.3%) (p=0.054). Same-day cytology results were available for 114 (97.4%) patients. A diagnostic plan was established at the initial visit in 71 (60.7%) cases, while the remaining patients had a median time to diagnostic plan of 11.5 days (IQR 8-16). The overall median time from referral to diagnostic plan was six days (IQR 4-16). Histopathological correlation was available for 62 (53%) patients. The risk of malignancy was 0% for benign, 45.5% for undetermined, 29.4% for suspicious for malignancy, and 85.2% for malignant cytology.
conclusionSurgeon-performed US-FNABs with same-day cytology achieved high adequacy rates, allowing most patients to receive a diagnostic plan during their initial visit. Residents performed similarly to consultants, supporting the feasibility of integrating US-FNAB into routine practice across different experience levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.